IN-VIVO INVESTIGATIONS OF CHRONIC INFLAMMATORY PAIN MODULATING POTENTIAL OF NIRANTHIN Authors: Gavarkar PS , SOMADE PM, CHAVAN RS, PHATAK RS, CHOPADE AR AND KENGAR SB
ABSTRACT
Background: It has been well referred that lignan family of natural products has
goodpharmacological potential. A lignan, Niranthin, 6-[(2R,3R)-3-[(3,4-dimethoxyphenyl)methyl]-4-
methoxy-2-(methoxymethyl)butyl]-4-methoxy-1,3-benzodioxole] is a common phytoconstituents
from various Phyllanthus species.
Objectives: This study aims to investigate chronic pain modulatory potential of Niranthin.
Materials and Methods: We have investigated the effects of Niranthin on chronic thermal and
mechanical hypersensitivities in rats, which were injected with 3% carrageenan in the left
gastrocnemius muscle and hyperalgesia to heat and mechanical stimuli was assessed before and at
varying times after injection, till end of 22 days after muscle insult. Histological changes and the
determination of prostaglandin E2 (PGE2) concentration were performed after the completion of drug
treatment protocol.
Results: Our finding noted that Niranthin causes hypersensitivityactivity, when administered
intraperitoneally. There was also reduction in prostaglandin E2 (PGE2) concentration observed during
our analysis.
Conclusion: To summarize, we wish to report chronic inflammatory pain modulating potential of
Niranthin in current pain model and are thought to be mediated via spinal or supraspinal neuronal
mechanisms, mainly inhibiting PGE2. Since, our current study is preliminary in nature, further in
detailed molecular investigation will be needed to predict drug-like candidature of Niranthin as pain
modulating agent.
Keywords: Niranthin; lignan; Anti-hyperalgesic activity; chronic muscle pain; pain modulating
potential Publication date: 01/09/2022 https://ijbpas.com/pdf/2022/September/MS_IJBPAS_2022_6413.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.9.6413